<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors</h2>
    <div class="badge">2025-09-22T13:00:00+00:00</div>
    <ul>
      <li>Earlier in his 35-year career, McDonald held leadership roles at Amgen, Novartis, and AstraZeneca.</li>
<li>Pictured: Chris McDonald, newest member of Cellares&#x27; Board of Advisors Veteran operations leader, with experience at Amgen, Novartis, AstraZeneca, and Kite/Gilead brings decades of manufacturing, quality, and supply chain expertise to support Cellares’ global IDMO Smart Factory expansion SOUTH SAN FRANCISCO, Calif., September 22, 2025 --( BUSINESS WIRE )-- Cellares , the world’s first Integrated Development and Manufacturing Organization (IDMO), today announced the…</li>
<li>About Cellares Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century.</li>
<li>Cell Shuttles™ and Cell Qs™ will be deployed in Cellares’ Smart Factories around the world, enabling each Smart Factory to produce 10 times as many cell therapy batches as a conventional CDMO with the same facility size and headcount.</li>
<li>McDonald most recently served as Senior Vice President and Global Head of Technical Operations (Tech Ops) at Kite, a Gilead Company, where he oversaw Global Manufacturing, Global Quality, Process Development, and Global Supply Chain across six worldwide sites and more than 3,000 employees.</li>
<li>He currently serves on the Board of Directors of Nucleus RadioPharma and has previously served on the board of Fosun Kite in Shanghai.</li>
<li>Chris has scaled one of the industry’s largest commercial cell therapy operations,&quot; said Fabian Gerlinghaus, co-founder and CEO of Cellares.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Cellares%20Appoints%20Former%20Kite%20Global%20Ops%20Leader%2C%20Christopher%20McDonald%2C%20to%20Board%20of%20Advisors%0A%E2%80%A2%20Earlier%20in%20his%2035-year%20career%2C%20McDonald%20held%20leadership%20roles%20at%20Amgen%2C%20Novartis%2C%20and%20AstraZeneca.%0A%E2%80%A2%20Pictured%3A%20Chris%20McDonald%2C%20newest%20member%20of%20Cellares%27%20Board%20of%20Advisors%20Veteran%20operations%20leader%2C%20with%20experience%20at%20Amgen%2C%20Novartis%2C%20AstraZeneca%2C%20and%20Kite%2FGilead%20brings%20decades%20of%20manufacturing%2C%20quality%2C%20and%20supply%20chain%20expertise%20to%20support%20Cellares%E2%80%99%20global%20IDMO%20Smart%20Factory%20expansion%20SOUTH%20SAN%20FRANCISCO%2C%20Calif.%2C%20September%2022%2C%202025%20--%28%20BUSINESS%20WIRE%20%29--%20Cellares%20%2C%20the%20world%E2%80%99s%20first%20Integrated%20Development%20and%20Manufacturing%20Organization%20%28IDMO%29%2C%20today%20announced%20the%E2%80%A6%0A%E2%80%A2%20About%20Cellares%20Cellares%20is%20the%20first%20Integrated%20Development%20and%20Manufacturing%20Organization%20%28IDMO%29%20and%20takes%20an%20Industry%204.0%20approach%20to%20mass%20manufacturing%20the%20living%20drugs%20of%20the%2021st%20century.%0A%E2%80%A2%20Cell%20Shuttles%E2%84%A2%20and%20Cell%20Qs%E2%84%A2%20will%20be%20deployed%20in%20Cellares%E2%80%99%20Smart%20Factories%20around%20the%20world%2C%20enabling%20each%20Smart%20Factory%20to%20produce%2010%20times%20as%20many%20cell%20therapy%20batches%20as%20a%20conventional%20CDMO%20with%20the%20same%20facility%20size%20and%20headcount.%0A%E2%80%A2%20McDonald%20most%20recently%20served%20as%20Senior%20Vice%20President%20and%20Global%20Head%20of%20Technical%20Operations%20%28Tech%20Ops%29%20at%20Kite%2C%20a%20Gilead%20Company%2C%20where%20he%20oversaw%20Global%20Manufacturing%2C%20Global%20Quality%2C%20Process%20Development%2C%20and%20Global%20Supply%20Chain%20across%20six%20worldwide%20sites%20and%20more%20than%203%2C000%20employees.%0A%E2%80%A2%20He%20currently%20serves%20on%20the%20Board%20of%20Directors%20of%20Nucleus%20RadioPharma%20and%20has%20previously%20served%20on%20the%20board%20of%20Fosun%20Kite%20in%20Shanghai.%0A%E2%80%A2%20Chris%20has%20scaled%20one%20of%20the%20industry%E2%80%99s%20largest%20commercial%20cell%20therapy%20operations%2C%22%20said%20Fabian%20Gerlinghaus%2C%20co-founder%20and%20CEO%20of%20Cellares.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fcellares-appoints-former-kite-global-ops-leader-christopher-mcdonald-to-board-of%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/cellares-appoints-former-kite-global-130000194.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>